Important information about the LENALIDOMIDE TE ARAI Access Programme. Please ensure you read and understand all information on this page before continuing. If you have any questions regarding anything you read on this page please contact your healthcare professional.
All patients are required to read the Consumer Medicine Information below. This document provides information about LENALIDOMIDE TE ARAI and its use by you.
LENALIDOMIDE TE ARAI has different risks for different groups of people. Your Healthcare Professional will have determined which risk group you are in and discussed this with you. Please read the brochure which applies to your risk group below.
